HealthQuill type 2 diabetes
Research uncovers significant discrepancies in ingredient labels and presence of banned compounds
Health

Rosuvastatin may lower mortality compared to atorvastatin: Study

HQ Team November 9, 2024: A recent study indicates that rosuvastatin is associated with a slightly reduced risk of all-cause mortality and major.

Read More
Danish multinational pharmaceutical company Novo Nordisk’s end-stage trial in patients with fatty liver disease saw reduced liver scarring (fibrosis) and its resolution without worsening the condition.
Drugs Health Pharma

Novo Nordisk’s weight loss drug reduces live scarring in end-stage trial

Danish multinational pharmaceutical company Novo Nordisk’s end-stage trial in patients with fatty liver disease saw reduced liver scarring (fibrosis) and its resolution without.

Read More
Denmark’s Novo Nordisk declared its late-stage experimental once-weekly diabetes drug IcoSema achieved its primary endpoint of proving “non-inferiority” in lowering blood sugar levels.
Drugs Health Medical

Breakthrough treatment may end insulin use in type 2 diabetic patients

HQ Team October 15, 2024: A recent study presented at the United European Gastroenterology Week congress in Vienna unveiled a procedure that could.

Read More
Insulet Corporation, a tubeless insulin pump maker, got clearance from the US Food and Drug Administration to add diabetes type 2 adult patients 18 years or older, to the treatment regime.
Drugs Health Pharma

Regulator okays Insulet’s insulin pump in US to treat type 2 diabetes

Insulet Corporation, a tubeless insulin pump maker, got clearance from the US Food and Drug Administration to add diabetes type 2 adult patients.

Read More
AstraZeneca’s oral drug to treat type-2 diabetes in patients aged 10 years and above has got approval from the US drug regulator, according to a company statement.
Drugs Health Pharma

FDA approves AstraZeneca’s type-2 diabetes drug in US market

AstraZeneca’s oral drug to treat type-2 diabetes in patients aged 10 years and above has got approval from the US drug regulator, according.

Read More
Novo Nordisk’s diabetes drug Ozempic delayed the progression of kidney disease and cardiovascular and kidney death in 24% of people involved in trials, the company announced.
Drugs Health Pharma

Novo Nordisk says Ozempic reduces kidney disease progression 

HQ Team March 6, 2024: Novo Nordisk’s diabetes drug Ozempic delayed the progression of kidney disease and cardiovascular and kidney deaths in 24%.

Read More
obesity
Drugs Health Medical

Ultra-Processed Foods linked to over 30 adverse health outcomes

Bharti Jayshankar February 29, 2024: From packaged snacks to sugary drinks, the allure of ultra-processed foods (UPF) has become a staple in many.

Read More
Cancer patients and survivors who drink alcohol make their treatment less effective and raise their chances of the disease returning — an exigency often ignored by caretakers.
Drugs Health Medical Pharma

Medications for obesity show promise in curbing alcohol cravings

Bharti Jayshankar January 26, 2024: A recent study has uncovered an unexpected benefit of medications commonly prescribed for obesity and type 2 diabetes:.

Read More
Drugs Health Medical Pharma

Metformin may prevent dementia in diabetics, new research suggests 


HQ Team October 27, 2023: Millions of individuals managing diabetes rely on metformin to regulate their blood sugar levels. Recent research highlights the.

Read More
The global population of people living with diabetes may more than double to 1.3 billion from the current 529 million in the next 30 years, according to researchers at the University of Washington.
Drugs Health Pharma

Global diabetic population may more than double by 2050

HQ Team June 23, 2023: The global population of people living with diabetes may more than double to 1.3 billion from the current.

Read More